White matter hyperintensities on brain magnetic resonance in systemic sclerosis

Annals of the Rheumatic Diseases

Volumn 64, Issue 5, 2005, Pages 777-779

  Sardanelli, F ^a,e   Iozzelli, A ^a   Cotticelli, B ^a   Losacco, C ^b   Cutolo, M ^c   Sulli, A ^c   Nobili, F ^d   Rodriguez, G ^d  

^a Istituta Policlinica San Donato ^*  (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e University Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; SYSTEMIC DISEASE; SYSTEMIC SCLEROSIS; WHITE MATTER;

ADULT; AGED; BRAIN; BRAIN DISEASES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; SCLERODERMA, SYSTEMIC; STATISTICS, NONPARAMETRIC;

EID: 17644410433     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2003.018283     Document Type: Article

References (15)

1. Pearson JD. The endothelium: its role in scleroderma. Ann Rheum Dis 1991;50:866-71.
2. Blann AD, Illingworth K, Layson MIV. Mechanisms of endothelial damage in systemic sclerosis and Raynaud's phenomenon. J Rheumatol 1993;20:1325-30.
3. Seibold JR. Scleroderma. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB, eds. Textbook of rheumatology. 5th ed. Philadelphia: Sounders, 1997:1133-62.
4. Tuffanelli D, Winkelmann RK. Systemic scleroderma: clinical study of 727 coses. Arch Dermatol 1961;84:359-71.
5. D'Angelo WA, Fries JF, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (scleroderma). Am J Med 1969;46:428-40.
6. Steven JL. Case of scleroderma with pronounced hemiatrophy of the face, body and extremities -death from ovarian tumor-account on the postmortem examination: a sequel. Glasgow Med J 1898;50:401-22.
7. Piper WN, Helwig EB. Progressive systemic sclerosis. Arch Dermatol 1955;72:535-46.
8. Pathak R, Gabor AJ. Scleroderma and central nervous system vasculitis. Stroke 1991;22:410-13.
9. Andonopoulos AP, Maraziotis T, Yarmenitis S, Papopetropoulos T. Multiple spontaneous intracerebral hemorrhages in a patient with progressive systemic sclerosis. Rev Rheum (Engl Ed) 1998;65:437-40.
10. Yukawa H, Kubo Y, Otawara Y, Kudo A, Tomitsuka N, Yoshida K, et al. A case of left occipital lobe hemorrhage in a patient with progressive systemic sclerosis: evaluation of cerebral angiography and histology. No Shinkei Geka 2000;28:1003-7.
11. Cutolo M, Nobili F, Sulli A, Pizzorni C, Briata M, Faelli F, et al. Evidence of cerebral hypoperfusion in scleroderma patients. Rheumatology (Oxford) 2000;39:1366-73.
12. Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000;27:155-60.
13. Blaszczyk M, Krolicki L, Krasu M, Glinska O, Jablonska S. Progressive facial hemiatrophy: central nervous system involvement and relationship with scleroderma en coup de sabre. J Rheumatol 2003;30:1997-2004.
14. Chung MH, Sum J, Morrell MJ, Horoupian DS. Intracerebral involvement in scleroderma en coup de sabre: report of a case with neuropathologic findings. Ann Neurol 1995;37:679-81.
15. Stone J, Franks AJ, Guthrie JA, Johnson MH. Scleroderma "en coup de sabre": pathological evidence of intracerebral inflammation. J Neurol Neurosurg Psychiatry 2001;70:382-5.